These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30685760)

  • 1. Growth Hormone Response to Oral Glucose Load: From Normal to Pathological Conditions.
    Hage M; Kamenický P; Chanson P
    Neuroendocrinology; 2019; 108(3):244-255. PubMed ID: 30685760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
    Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glucose tolerance coincides with abnormal release of growth hormone following a glucose load as well as in response to TRH in acromegaly.
    Zárate A; García IC; Morán C; Fonseca ME
    Horm Metab Res; 1986 Jun; 18(6):400-1. PubMed ID: 3089892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients.
    Shibasaki T; Masuda A; Hotta M; Yamauchi N; Hizuka N; Takano K; Demura H; Shizume K
    Life Sci; 1989; 44(6):431-8. PubMed ID: 2563893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly Cases Exhibiting Increased Growth Hormone Levels during Oral Glucose Loading with Preadministration of Dipeptidyl Peptidase-4 Inhibitor.
    Oba-Yamamoto C; Kameda H; Miyoshi H; Sekizaki T; Takase T; Yanagimachi T; Fujita Y; Nomoto H; Cho KY; Nakamura A; Nagai S; Atsumi T
    Intern Med; 2021; 60(15):2375-2383. PubMed ID: 34334589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients.
    Düğer H; Bostan H; Deryol HY; İmga NN; Uçan B; Çalapkulu M; Hepşen S; Akhanlı P; Gül Ü; Sencar ME; Çakal E; Özdemir Ş; Kızılgül M
    Growth Horm IGF Res; 2022 Dec; 67():101501. PubMed ID: 36166917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide.
    Díez JJ; Iglesias P; Gómez-Pan A
    J Endocrinol Invest; 2001 May; 24(5):303-9. PubMed ID: 11407648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD; Bonert VS; Mirocha JM; Melmed S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
    Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
    Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-dependent insulinotropic polypeptide induced growth hormone secretion in acromegaly.
    Umahara M; Okada S; Ohshima K; Mori M
    Endocr J; 2003 Oct; 50(5):643-50. PubMed ID: 14614222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
    Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of suppression of growth hormone levels following a 75g oral glucose tolerance test.
    Nazaimoon WM; Ng ML; Satgunasingam N; Khalid BA
    Med J Malaysia; 1992 Jun; 47(2):103-9. PubMed ID: 1494329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of activity in postoperative acromegalics--plasma growth hormone levels during oral glucose tolerance test, daytime blood sampling and urinary GH excretion.
    Hattori N; Shimatsu A; Tanoh T; Koshiyama H; Kato Y; Imura H
    Endocrinol Jpn; 1990 Oct; 37(5):629-37. PubMed ID: 2128272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The altered plasma amino acid pattern is responsible for the paradoxical growth hormone response to the oral glucose tolerance test in liver cirrhosis.
    Martina V; Tagliabue M; Bruno GA; Bonetti G; Brancaleoni V; Meineri I; Saracco G; Zumpano E; Manieri C; Camanni F
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):175-80. PubMed ID: 9579229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.